222 related articles for article (PubMed ID: 21853673)
1. [The characteristics of Gram-positive bacteria isolated from skin lesions observed in ambulatory patients and the assessment of their susceptibility to antimicrobial drugs].
Sikora A; Kozioł-Montewka M; Bogut A
Przegl Lek; 2011; 68(4):196-201. PubMed ID: 21853673
[TBL] [Abstract][Full Text] [Related]
2. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.
Sader HS; Farrell DJ; Jones RN
Int J Antimicrob Agents; 2010 Jul; 36(1):28-32. PubMed ID: 20444576
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.
Eisenstein BI; Oleson FB; Baltz RH
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S10-5. PubMed ID: 20067387
[TBL] [Abstract][Full Text] [Related]
5. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
Nenoff P; Haustein UF; Hittel N
Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398
[TBL] [Abstract][Full Text] [Related]
6. [Antibiotic therapy by suppurative diseases of the abdominal cavity and soft tissues].
Sazhin VP; Bodrova NG; Klimov DE; Iurishchev VA; Avdovenko AL; Sazhin IV
Khirurgiia (Mosk); 2010; (6):4-9. PubMed ID: 20559216
[TBL] [Abstract][Full Text] [Related]
7. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Krause KM; Barriere SL; Kitt MM; Benton BM
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):181-5. PubMed ID: 20846593
[TBL] [Abstract][Full Text] [Related]
9. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
[TBL] [Abstract][Full Text] [Related]
10. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C
Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.
Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Kim M
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):273-9. PubMed ID: 24661685
[TBL] [Abstract][Full Text] [Related]
12. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
Shitaye D; Asrat D; Woldeamanuel Y; Worku B
Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
[TBL] [Abstract][Full Text] [Related]
14. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR;
Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
16. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
Ashour HM; el-Sharif A
J Clin Oncol; 2007 Dec; 25(36):5763-9. PubMed ID: 18089873
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
Kern WV
Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
[TBL] [Abstract][Full Text] [Related]
18. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Biek D; Critchley IA; Riccobene TA; Thye DA
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
20. [Empirical antibiotic therapy of complicated skin and soft tissue infections in dermatological practice].
Magyar A; Garaczi E; Hajdú E; Kemény L
Orv Hetil; 2011 Feb; 152(7):252-8. PubMed ID: 21296734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
